Literature DB >> 9506735

Reproductive dysfunction in women with Albright's hereditary osteodystrophy.

A B Namnoum1, G R Merriam, A M Moses, M A Levine.   

Abstract

Most individuals with Albright's hereditary osteodystrophy (AHO) have deficient expression or function of G(s alpha), the alpha subunit of the guanine nucleotide binding protein that stimulates adenylyl cyclase, and are resistant to parathyroid hormone (PTH) and other hormones that act via stimulation of adenylyl cyclase. To determine the incidence and etiology of ovarian dysfunction in women with AHO, we examined the reproductive history and hypothalamic-pituitary-ovarian axis in 17 affected women aged 17-43 yr. All patients had typical PTH resistance and an approximately 50% reduction in erythrocyte G(s alpha) activity, (0.43 +/- 0.03 vs. 0.92 +/- 0.08 for normal control subjects, P < 0.001). Fourteen of the 17 patients (76%) were oligomenorrheic or amenorrheic, more than half had delayed or incomplete sexual development, and only two had a history of earlier pregnancy. Most women were mildly hypoestrogenic, with normal to slightly elevated serum gonadotropin levels. Computer analysis of 24 hour LH measurement showed that the frequency of LH peaks/24 h in AHO women varied widely, but as a group they were not statistically different from a group of normal women studied in the early follicular phase. Administration of 100 microg synthetic GnRH produced normal FSH and LH responses. We conclude that reproductive dysfunction is common in women with AHO and probably represents partial resistance to gonadotropins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506735     DOI: 10.1210/jcem.83.3.4652

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1.

Authors:  Suzanne Jan de Beur; Changlin Ding; Emily Germain-Lee; Justin Cho; Alexander Maret; Michael A Levine
Journal:  Am J Hum Genet       Date:  2003-07-11       Impact factor: 11.025

Review 3.  Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications.

Authors:  Patrick McMullan; Emily L Germain-Lee
Journal:  Curr Osteoporos Rep       Date:  2022-02-28       Impact factor: 5.096

4.  Deletion of Gαq/11 or Gαs Proteins in Gonadotropes Differentially Affects Gonadotropin Production and Secretion in Mice.

Authors:  George A Stamatiades; Chirine Toufaily; Han Kyeol Kim; Xiang Zhou; Iain R Thompson; Rona S Carroll; Min Chen; Lee S Weinstein; Stefan Offermanns; Ulrich Boehm; Daniel J Bernard; Ursula B Kaiser
Journal:  Endocrinology       Date:  2022-02-01       Impact factor: 4.736

5.  Pseudohypoparathyroidism: a rare but important cause of hypocalcaemia.

Authors:  Pui Lin Chong; Darryl R Meeking
Journal:  BMJ Case Rep       Date:  2013-01-22

Review 6.  Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology.

Authors:  Lee S Weinstein; Tao Xie; Qing-Hong Zhang; Min Chen
Journal:  Pharmacol Ther       Date:  2007-04-21       Impact factor: 12.310

7.  PTH receptor signaling in osteoblasts regulates endochondral vascularization in maintenance of postnatal growth plate.

Authors:  Tao Qiu; Lingling Xian; Janet Crane; Chunyi Wen; Matthew Hilton; William Lu; Peter Newman; Xu Cao
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

8.  G-protein Stimulatory α Subunit Is Involved in Osteogenic Activity in Osteoblastic Cell Line SaOS-2 Cells.

Authors:  Miwa Yamazaki; Akira Suzuki; Keiichi Ozono; Toshimi Michigami
Journal:  Clin Pediatr Endocrinol       Date:  2006-04-29

9.  Characteristic Height Growth Pattern in Patients with Pseudohypoparathyroidism: Comparison between Type 1a and Type 1b.

Authors:  Kaori Kinoshita; Masanori Minagawa; Michiko Anzai; Yumiko Sato; Itsuro Kazukawa; Kyoko Shimohashi; Setsuo Ota; Yoichi Kohno
Journal:  Clin Pediatr Endocrinol       Date:  2007-02-07

Review 10.  Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Aurora Garcia Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen A T Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Manasori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebeca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Horm Res Paediatr       Date:  2020-08-05       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.